Sean A. McCarthy
2021
In 2021, Sean A. McCarthy earned a total compensation of $4.3M as Chief Executive Officer and Chairman of the Board of Directors at CytomX Therapeutics, a 52% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $359,500 |
|---|---|
| Option Awards | $2,931,890 |
| Salary | $615,825 |
| Stock Awards | $427,200 |
| Other | $5,000 |
| Total | $4,339,415 |
McCarthy received $2.9M in option awards, accounting for 68% of the total pay in 2021.
McCarthy also received $359.5K in non-equity incentive plan, $615.8K in salary, $427.2K in stock awards and $5K in other compensation.
Rankings
In 2021, Sean A. McCarthy's compensation ranked 3,057th out of 12,415 executives tracked by ExecPay. In other words, McCarthy earned more than 75.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,057 out of 12,415 | 75th |
Division Manufacturing | 1,221 out of 5,505 | 78th |
Major group Chemicals And Allied Products | 489 out of 2,375 | 79th |
Industry group Drugs | 432 out of 2,096 | 79th |
Industry Pharmaceutical Preparations | 294 out of 1,546 | 81st |
Source: SEC filing on April 27, 2022.
McCarthy's colleagues
We found five more compensation records of executives who worked with Sean A. McCarthy at CytomX Therapeutics in 2021.
2021
Amy Peterson
CytomX Therapeutics
Chief Operating Officer
2021
Jeff Landau
CytomX Therapeutics
Senior Vice President and Chief Business Officer
2021
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
2021
Lloyd Rowland
CytomX Therapeutics
General Counsel
2021
Carlos Campoy
CytomX Therapeutics